| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |